会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 67. 发明申请
    • Nonsteroidal immunomodulating kit and composition and uses thereof
    • 非甾体免疫调节试剂盒及其组合物和用途
    • US20050232869A1
    • 2005-10-20
    • US11078902
    • 2005-03-11
    • Dov TamarkinMeir EiniDoron Friedman
    • Dov TamarkinMeir EiniDoron Friedman
    • A61K8/04A61K8/67A61K31/07A61K31/203A61L9/04A61M11/00A61Q19/00A61K7/42
    • A61K9/122A61K8/046A61K8/671A61K9/0014A61K9/10A61K31/07A61K31/203A61Q19/00
    • A composition and therapeutic kit including an aerosol packaging assembly including a container accommodating a pressurized product and an outlet capable of releasing a foamable composition, including a nonsteroidal immunomodulating agent as a foam. The pressurized product includes a foamable composition including: a) a container accommodating a pressurized product; and b) an outlet capable of releasing the pressurized product as a foam; wherein the pressurized product comprises a foamable composition including: i. a nonsteroidal immunomodulating agent; ii. at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, a polar solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight; iii. a surface-active agent; iv. about 0.1% to about 5% by weight of a therapeutically active foam adjuvant, selected from the group consisting of a fatty alcohol, a fatty acid, a hydroxyl fatty acid; and mixtures thereof; v. about 0.01 % to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; vi. water; and vii. liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
    • 一种组合物和治疗试剂盒,其包括气溶胶包装组件,其包括容纳加压产品的容器和能够释放可发泡组合物的出口,其包括作为泡沫的非甾体免疫调节剂。 加压产品包括可发泡组合物,其包括:a)容纳加压产品的容器; 和b)能够释放作为泡沫的加压产品的出口; 其中所述加压产品包括可发泡组合物,其包含:i。 非甾体免疫调节剂; ii。 选自浓度为约2%至约50%重​​量的至少一种选自疏水性有机载体,极性溶剂,软化剂及其混合物的有机载体; iii。 表面活性剂; iv。 约0.1重量%至约5重量%的治疗活性泡沫佐剂,其选自脂肪醇,脂肪酸,羟基脂肪酸; 及其混合物; 约0.01重量%至约5重量%的至少一种选自生物粘附剂,胶凝剂,成膜剂和相变剂的聚合物添加剂; vi。 水; 和vii。 液化或压缩气体推进剂的浓度为总组合物重量的约3%至约25%。
    • 68. 发明申请
    • Retinoid immunomodulating kit and composition and uses thereof
    • 类视黄醇免疫调节试剂盒及其组合物和用途
    • US20050205086A1
    • 2005-09-22
    • US11078948
    • 2005-03-11
    • Dov TamarkinMeir EiniDoron Friedman
    • Dov TamarkinMeir EiniDoron Friedman
    • A61K8/04A61K8/67A61K31/07A61K31/203A61L9/04A61M11/00A61Q19/00
    • A61Q19/00A61K8/046A61K8/671A61K9/0014A61K9/122A61K31/07A61K31/203
    • A composition and therapeutic kit including an aerosol packaging assembly including a container accommodating a pressurized product and an outlet capable of releasing a foamable composition, including a retinoid as a foam. The pressurized product includes a foamable composition including: a container accommodating a pressurized product; and an outlet capable of releasing the pressurized product as a foam; wherein the pressurized product comprises a foamable composition including: i. a retinoid; ii. at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, a polar solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight; iii. a surface-active agent; iv. about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; v. water; and vi. liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition. The composition further may include a therapeutically active foam adjuvant, selected from the group consisting of a fatty alcohol, a fatty acid, a hydroxyl fatty acid; and mixtures thereof.
    • 一种组合物和治疗试剂盒,其包括气溶胶包装组件,其包括容纳加压产品的容器和能够释放可发泡组合物的出口,其包含类视黄醇作为泡沫。 加压产品包括可发泡组合物,其包括:容纳加压产品的容器; 以及能够释放作为泡沫的加压产品的出口; 其中所述加压产品包括可发泡组合物,其包含:i。 类视黄醇 ii。 选自浓度为约2%至约50%重​​量的至少一种选自疏水性有机载体,极性溶剂,软化剂及其混合物的有机载体; iii。 表面活性剂; iv。 约0.01重量%至约5重量%的至少一种选自生物粘附剂,胶凝剂,成膜剂和相变剂的聚合物添加剂; v。水 和vi。 液化或压缩气体推进剂的浓度为总组合物重量的约3%至约25%。 组合物还可以包括治疗活性的泡沫佐剂,其选自脂肪醇,脂肪酸,羟基脂肪酸; 及其混合物。